| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |